Comparison between the inhibitory activities of sangivamycin and thiosangivamycin on nuclear ribonucleic acid synthesis in L1210 cells in vitro.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D002467:Cell Nucleus / Q000187:drug effects / Q000378:metabolism*; D002478:Cells, Cultured; D004273:DNA, Neoplasm / Q000096:biosynthesis; D007939:Leukemia L1210 / Q000378:metabolism*; D051379:Mice; D011741:Pyrimidine Nucleosides / Q000494:pharmacology*; D012334:RNA, Neoplasm / Q000096:biosynthesis*; D012436:S-Adenosylmethionine / Q000378:metabolism; D013872:Thionucleosides / Q000494:pharmacology*; D013997:Time Factors; D014544:Uridine Triphosphate / Q000378:metabolism
D000903:Antibiotics, Antineoplastic; D004273:DNA, Neoplasm; D011741:Pyrimidine Nucleosides; D012334:RNA, Neoplasm; D013872:Thionucleosides; C005699:sangivamycin; C023564:thiosangivamycin; D012436:S-Adenosylmethionine; D014544:Uridine Triphosphate